PPT-Type I / Type II Error Control in Drug Development

Author : luanne-stotts | Published Date : 2017-12-14

Andy Grieve Head of Centre of Excellence for Statistical Innovation UCB Pharma UK PSI Annual Conference London 1417 May 2017 1 2015 2016 2002 2003 2006 2016 2007

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Type I / Type II Error Control in Drug D..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Type I / Type II Error Control in Drug Development: Transcript


Andy Grieve Head of Centre of Excellence for Statistical Innovation UCB Pharma UK PSI Annual Conference London 1417 May 2017 1 2015 2016 2002 2003 2006 2016 2007 2017 66666 2017. The bit stream representation of a symbol is called the codeword of that symbol Di64256erent error control mechanisms Linear Block Codes Repetition Codes Convolution Codes brPage 2br Linear Block Codes A code is linear if two codes are added using m Confirm what the data reveal: Inferential statistics. All this information is in Chapters 11 & 12 of text. For most research today, this step of the plan would use. . inferential statistics. (such as t-test and analysis of variance). . Research shows . that . New Zealand ranked ninth (. last!. ) in workplace health and safety performance for the 2005-2008 period out of nine OECD countries, with:. 102 fatalities per . annum . . Suman Jana. 1. , . Yuan Kang. 1. , Samuel Roth. 2. , Baishakhi Ray. 3. 1. Columbia University. 2. Ohio Northern University. 3. University of Virginia. Incorrect error handling. : a major source. . of. STEADY-STATE ERROR. The difference between the output and the reference in the steady state was defined as the steady-state error.. In the real world, because of friction and other imperfections and the natural composition of the system, the steady state of the output response seldom agrees exactly with the reference. . for mobile platform. The objective of a kinematic controller is to follow a trajectory described by its position and/or velocity profiles as function of time.. Motion control is not straight forward because mobile robots are typically non-. Introduction. All transmitted signals will contain some rate of error (>0%). Popular error control methods include:. Parity bits (add a 1 or 0 to the end of each seven bits). Longitudinal redundancy checking (LRC). BY GROUP 5. 17/MHS01/17. 4. . KWAME-OKPU E.A . OGHENEOVU. 17/MHS01/159 IMOYIN-OMENE . EMUOBONUVIE . 17/MHS01/0. 2. 6 AFENO-EBOH VOKE. 17/MHS03/007 AYEMOBUWA OMOTAYO. 17/MHS07/005 . BELLO AISHA . . Introduction. All transmitted signals will contain some rate of error (>0%). Popular error control methods include:. Parity bits (add a 1 or 0 to the end of each seven bits). Longitudinal redundancy checking (LRC). John Michael Sauer, PhD. Critical Path Institute’s Predictive Safety Testing Consortium. Tucson, Arizona. jsauer@c-path.org. So you have a biomarker(s) that you want to use for regulatory decision making…now what do you do?. Travis R. . Goodwin. 1. , . Dina . Demner-Fushman. 1. , Kin Wah Fung. 1. , . and . Phong. Do. 2. 1. . Lister Hill National Center for Biomedical Communications, . U.S. National Library of Medicine.  = 0.05. ANOVA: Graphical. Example: ANOVA terms. Treatment 1. Treatment 2. Treatment. 3. 1. y. 11. = 48. y. 21. = 40. y. 31. = 39. 2. y. 12. = 39. y. 22. = 48. y. 32. = 30. 3. y. 13. = 42. In . statistics. , a . Type I error.  is a false positive conclusion, while a . Type II error.  is a false negative conclusion.. The probability of making a Type I error is the significance level, or alpha (α), while the probability of making a Type II error is beta (β). These risks can be minimized through careful planning in your study design.. . Any noxious change which is . Suspected to be due to a drug. At. doses normally . used in man. May requires treatment or decrease in dose or . Caution in the future use of the same drug. ADVERSE DRUG EVENT (ADE.

Download Document

Here is the link to download the presentation.
"Type I / Type II Error Control in Drug Development"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents